JSDT-14-1159

Mandibular advancement device therapy in obstructive sleep apnea and snoring in community dental care: two-year follow-up study on self-reported sleep quality, side effects, and compliance Vuorjoki-Ranta, T.R.; Lobbezoo, F.; Tuomilehto, H.; Könönen, M.; Pihakari, A.; Ahlberg, J. Published in: Journal of Sleep Disorders & Therapy DOI: 10.4172/2167-0277.1000180 Link to publication Citation for published version (APA): Vuorjoki-Ranta, T. R., Lobbezoo, F., Tuomilehto, H., Könönen, M., Pihakari, A., & Ahlberg, J. (2014). Mandibular advancement device therapy in obstructive sleep apnea and snoring in community dental care: two-year followup study on self-reported sleep quality, side effects, and compliance. Journal of Sleep Disorders & Therapy, 3(5), 1000180. https://doi.org/10.4172/2167-0277.1000180 General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. Abstract Study background: Obesity is constantly increasing health problem worldwide and so are its detrimental consequences, including obstructive sleep apnea (OSA). Mandibular advancement devices (MADs) are proven to be efficient in treating mild to moderate OSA and snoring. We followed for two years 103 patients treated with a titrable MAD in a Community Dental Care setting. Methods: A follow-up questionnaire was mailed in 2012 to 124 patients who had participated in a survey 2010 and given their consent for further study. Results: Of all the 103 respondents 85% (n=88) still used MAD. Subjective tiredness (p<0.05) and the presence of any snoring (p<0.01) were reported more often in the long-term study than in the short-term study. In contrast, difficulty in initiating sleep with the device in situ was seen less often (p<0.05). According to the logistic regression, reduced loud snoring was significantly associated with the compliance of frequent wear of MAD (p<0.05). The majority (82%) of the patients also reported a positive impact of MAD in social (family) life due to reduced loud snoring. Conclusion: Titrable MAD is a noteworthy treatment modality for mild to moderate OSA and especially snoring. Compliance in using MADs and reported subjective health seem to remain at good level. General dentists could probably perform a great part of the care. However, possible worsening of OSA and side effects of MADs should be borne in mind